Maze Therapeutics, Inc. (MAZE) Revenue History
Maze Therapeutics, Inc. (MAZE) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2023-12-31 | N/A |
| 2024-12-31 | $167.50M |
| 2025-12-31 | N/A |
How MAZE compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | $218.71M |
| RGNX | REGENXBIO Inc. | $170.44M |
| STIM | Neuronetics Inc. | $149.16M |
| OSUR | OraSure Technologies Inc. | $115.02M |
| AGEN | Agenus Inc. | $114.20M |
These are five companies in the same sector as MAZE with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Maze Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("MAZE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MAZE | $29.43 | +1.73% | 0.28M |
| 3 | ||||
| 4 | ||||
| 5 |